INSIGHTS ON FACILITY DESIGN
-
Establishing The Right-Sized Tech Ops Strategy In An Uncertain Market
A quantitative and qualitative tech ops strategy gives biotech companies a sound roadmap to guide them through the winding road of drug development and attract investors.
-
Single-Use, Stainless Steel, Or Both? Key Points To Consider
Mass-producing cutting-edge, novel therapeutics is complex. First, companies must choose between single-use materials, stainless steel equipment, or a flexible solution that includes both elements.
-
How To Clean Your Incubator Shaker
Cleaning an incubator shaker is critical for successful cultivation, and integrating this type of maintenance into the routine management of your biosciences laboratory doesn't have to be difficult.
-
Creating Accurate, Efficient, And Effective CDMO Project Proposals
To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.
-
Continuous Growth In Advanced Therapies8/15/2023
As the industry continues to see innovation in manufacturing approaches, the Project Farma team discusses how advanced therapies differ from traditional medicines.
-
Evolving With Our Customers - A $100 Million Expansion6/16/2023
To meet the demand for innovative therapeutics and drug delivery systems, manufacturing partners must also evolve to meet customer needs and deliver safe, high-quality products to patient populations.
-
Audience Q&A6/7/2023
Listen in to real-time questions and answers from the audience. During “Building An In-House Cell & Gene Manufacturing Facility – Best Practices & Lessons Learned.”
-
Speed To Clinic6/7/2023
Does or should speed to clinic impact a company’s decision to build versus buy? Explore this question and others along with lessons regarding capacity and meeting anticipated demand.
-
Building The Team6/7/2023
When building a production line from lab-based processes, sometimes staff primarily familiar with research might not know the specifics of regulations relating to late-stage drug production.
FACILITY DESIGN SOLUTIONS
-
Ensure your ability to continue growing healthy cells by working with a reliable team of service engineers to establish the dependable, continuous operation of your incubation shakers.
-
1,500 mL max rotor capacity 100,000 max RPM 802,400 x g
With all the features you expect, along with many advanced functions you won’t find anywhere else, the Optima™ XE simplifies use while offering secure loading for efficient, worry-free separations.
-
Address biomanufacturing capacity with flexibility, speed and confidence.
-
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
Explore Single-Use Fluid Transfer Assemblies that can streamline your development and manufacturing by providing a high-quality, rapid, and disposable sterile fluid transfer solution.